A rare case of GATA1 negative chemoresistant acute megakaryocytic leukemia in an 8-month-old infant with trisomy 21

Pediatr Blood Cancer. 2010 Jul 1;54(7):1048-9. doi: 10.1002/pbc.22331.

Abstract

Children with Down syndrome (DS) have a unique form of acute megakaryocytic leukemia (AMKL) characterized by the presence of mutations in the GATA1 gene leading to increased chemosensitivity and a favorable outcome. We describe an 8-month-old male with DS who was diagnosed with AMKL without a mutation in the GATA1 gene. The patient was treated according to the DS-AML-regimen but his disease progressed and he succumbed 9 months later. This rare case of DS AMKL without a GATA1 mutation with an unfavorable outcome suggests that GATA1 testing may play a useful role in initial stratification.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Down Syndrome / complications*
  • Drug Resistance, Neoplasm
  • Fatal Outcome
  • GATA1 Transcription Factor / genetics*
  • Humans
  • Infant
  • Leukemia, Megakaryoblastic, Acute / complications*
  • Leukemia, Megakaryoblastic, Acute / drug therapy
  • Male
  • Mutation

Substances

  • Antineoplastic Agents
  • GATA1 Transcription Factor
  • GATA1 protein, human